- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2018
- Public Summary Document (PSD) July 2018 PBAC Meeting - PDF
- Public Summary Document (PSD) July 2018 PBAC Meeting - Word
Ixekizumab – July 2018
Ixekizumab: Injection 80 mg in 1 ml single dose pre-filled pen; Injection 80 mg in 1 ml single dose
Last updated
26 October 2018